Article info

Download PDFPDF
Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

Authors

  1. Correspondence to Dr Ulrich Moser; u-moser{at}t-online.de
View Full Text

Citation

Moser U
Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

Publication history

  • Accepted June 11, 2021
  • First published July 6, 2021.
Online issue publication 
July 06, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.